Prothena Corp Public (PRTA) Total Current Liabilities (2012 - 2026)
Prothena Corp Public (PRTA) posted quarterly Total Current Liabilities of $32.5 million for Q1 2026, down 32.9% year-over-year from $48.5 million in Q1 2025, and down 20.39% quarter-over-quarter from $40.8 million in Q4 2025.
Prothena Corp Public (PRTA) Total Current Liabilities (2012 - 2026) Analysis & Trends
Prothena Corp Public's Total Current Liabilities history runs 15 years deep, the most recent figure standing at $32.5 million for Q1 2026.
- In Q1 2026, Total Current Liabilities fell 32.9% year-over-year to $32.5 million; the TTM figure through Mar 2026 stood at $32.5 million (down 32.9% YoY), while the FY2025 annual figure was $40.8 million, down 15.79% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $32.5 million, down from $40.8 million in the prior quarter.
- The five-year high for Total Current Liabilities was $71.6 million in Q2 2023, with the low at $32.5 million in Q1 2026.
- The 5-year median for Total Current Liabilities is $48.5 million (2024), against an average of $49.1 million.
- The sharpest annual moves came in 2023 and 2024: Total Current Liabilities surged 78.44% in 2023, then plunged 34.68% in 2024.
- Prothena Corp Public's Total Current Liabilities stood at $50.1 million in 2022, then grew by 13.45% to $56.9 million in 2023, then declined by 14.75% to $48.5 million in 2024, then declined by 15.79% to $40.8 million in 2025, then fell by 20.39% to $32.5 million in 2026.
- Business Quant data shows PRTA's Total Current Liabilities at $32.5 million in Q1 2026, $40.8 million in Q4 2025, and $51.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.58 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 354.06 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 2.12 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4.22 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 630.93 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.51 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 438.74 Mn |
| 10 | Prothena Corp Public | 458.45 Mn | 170.25 Mn | - | 11.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.66 Mn |
| Mar 31, 2026 | 32.52 Mn |
| Dec 31, 2025 | 40.84 Mn |
| Sep 30, 2025 | 51.44 Mn |
| Jun 30, 2025 | 67.81 Mn |
| Mar 31, 2025 | 48.46 Mn |
| Dec 31, 2024 | 48.50 Mn |
| Sep 30, 2024 | 46.42 Mn |
| Jun 30, 2024 | 46.74 Mn |
| Mar 31, 2024 | 43.27 Mn |
| Dec 31, 2023 | 56.89 Mn |
| Sep 30, 2023 | 53.37 Mn |
| Jun 30, 2023 | 71.57 Mn |
| Mar 31, 2023 | 48.88 Mn |
| Dec 31, 2022 | 50.15 Mn |
| Sep 30, 2022 | 50.60 Mn |
| Jun 30, 2022 | 40.11 Mn |
| Mar 31, 2022 | 36.50 Mn |
| Dec 31, 2021 | 33.45 Mn |
| Sep 30, 2021 | 29.20 Mn |